Back
Cytokinetics, Inc. 10K Form
Buy
63
CYTK
Cytokinetics, Inc.
Last Price:
$66.73
Seasonality Move:
5.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | CYTK/Cytokinetics, Inc. Quarterly |
| 2023-11-03 | 10Q | CYTK/Cytokinetics, Inc. Quarterly |
| 2023-08-03 | 10Q | CYTK/Cytokinetics, Inc. Quarterly |
| 2023-05-05 | 10Q | CYTK/Cytokinetics, Inc. Quarterly |
| 2022-11-04 | 10Q | CYTK/Cytokinetics, Inc. Quarterly |
| 2022-08-05 | 10Q | CYTK/Cytokinetics, Inc. Quarterly |
Receive CYTK News And Ratings
See the #1 stock for the next 7 days that we like better than CYTK
CYTK Financial Statistics
Sales & Book Value
| Annual Sales: | $88M |
|---|---|
| Cash Flow: | $-148.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-5.37 |
| Price / Book: | 61.87 |
Profitability
| EPS (TTM): | -6.53350 |
|---|---|
| Net Income (TTM): | $-785M |
| Gross Margin: | $77.9M |
| Return on Equity: | 0% |
| Return on Assets: | -58.12% |
Cytokinetics, Inc. Earnings Forecast
Key Cytokinetics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 26 years for CYTK is 88.50%.
-
The Selling, General & Administrative Expenses for CYTK have been equal to 322.89% of Gross Profit Margin.
-
The Research & Development expenses have been 461.05% of Revenue.
-
The Net Earning history of CYTK is -891.60% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 12 years.
Cytokinetics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CYTK |
| CUSIP: | 23282W |
| Website: | cytokinetics.com |
Debt
| Debt-to-Equity Ratio: | -1.95 |
|---|---|
| Current Ratio: | 4.53 |
| Quick Ratio: | 4.46 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CYTK Technical Analysis vs Fundamental Analysis
Buy
63
Cytokinetics, Inc. (CYTK)
is a Buy
Is Cytokinetics, Inc. a Buy or a Sell?
-
Cytokinetics, Inc. stock is rated a BuyThe current Cytokinetics, Inc. [CYTK] share price is $66.73. The Score for CYTK is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.